Dual oral iron chelation with deferasirox and deferiprone in transfusion-dependent β-thalassemia: a narrative review of efficacy, safety, and practical application. [PDF]
James V, Emeghebo KI.
europepmc +1 more source
The effects of deferiprone and deferasirox on the structure and function of β-thalassemia hemoglobin [PDF]
Transfusional iron overload is a major cause of morbidity and mortality in thalassemia, sickle-cell disease and other chronic anemias. To overcome these problems, orally bio available iron chelators, deferiprone and deferasirox, were used for the ...
دیوسالار, عادله +14 more
core
Neutropenia in adult patients with thalassemia receiving deferiprone: a 10-year experience from a large thalassemia cohort. [PDF]
Lertvipapath P +3 more
europepmc +1 more source
Triple Iron Chelation in Transfusion Dependent Thalassemia: A Case Report. [PDF]
Njue L, Häfliger E, Rovó A.
europepmc +1 more source
Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias. [PDF]
Sheth S +6 more
europepmc +1 more source
New insights on iron overload-mediated lysosomal membrane rupture in liver regeneration following acetaminophen-induced liver injury. [PDF]
Zhu H, Cao P, Ding WX.
europepmc +1 more source
The in vitro activity of iron chelator deferiprone against Candida (Candidozyma) auris in combination with antifungal agents. [PDF]
Tóth Z +7 more
europepmc +1 more source
Luspatercept in Transfusion-Dependent Thalassemia With Red Blood Cell Antibodies: A Case Series. [PDF]
Teawtrakul N.
europepmc +1 more source
Machine learning-assisted screening of small-molecule drugs for suppressing protein aggregation and ROS generation based on ECL and CV dual-mode signals amplified by DNA. [PDF]
Shi J +7 more
europepmc +1 more source
Emerging Roles of Ferritinophagy, Mitophagy and Chaperone-Mediated Autophagy in Pathogen-Induced Ferroptosis During Mastitis. [PDF]
Khan MZ +7 more
europepmc +1 more source

